1. Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
    Xinping Cao et al, 2023, Current Treatment Options in Oncology CrossRef
  2. Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
    Shambavi Richard et al, 2022, BioDrugs CrossRef
  3. CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
    Xiaomin Zhang et al, 2022, Frontiers in Immunology CrossRef
  4. Relapsed or refractory large B‐cell lymphoma after chimeric antigen receptor T‐cell therapy: Current challenges and therapeutic options
    Raul Del Toro‐Mijares et al, 2023, British Journal of Haematology CrossRef
  5. Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
    Jack Fisher et al, 2022, Vaccines CrossRef
  6. XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression
    Jack G. Fisher et al, 2023, Leukemia CrossRef
  7. Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E
    Jack G. Fisher et al, 2021, Frontiers in Oncology CrossRef
  8. Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors
    Adam F. Binder et al, 2023, Frontiers in Immunology CrossRef
  9. Exportin 1 governs the immunosuppressive functions of myeloid-derived suppressor cells in tumors through ERK1/2 nuclear export
    Saeed Daneshmandi et al, 2024, Cellular & Molecular Immunology CrossRef
  10. Treatment of multiple myeloma with selinexor: a review
    Qianlei Huang et al, 2024, Therapeutic Advances in Hematology CrossRef
  11. A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma
    Di Wang et al, 2023, Journal of Translational Medicine CrossRef
  12. A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma
    Benjamin A Derman et al, 2023, European Journal of Haematology CrossRef
  13. Therapeutic Targeting of Exportin-1 in Childhood Cancer
    Basia Galinski et al, 2021, Cancers CrossRef